The estimated Net Worth of Thomas E Jr Polen is at least $18.2 millió dollars as of 15 August 2022. Mr. Polen owns over 15,000 units of Becton Dickinson & Co stock worth over $10,253,850 and over the last 10 years he sold BDX stock worth over $1,923,595. In addition, he makes $6,029,970 as President, Chief Executive Officer, Chief Operating Officer és Director at Becton Dickinson & Co.
Thomas has made over 17 trades of the Becton Dickinson & Co stock since 2015, according to the Form 4 filled with the SEC. Most recently he exercised 15,000 units of BDX stock worth $2,518,650 on 15 August 2022.
The largest trade he's ever made was exercising 15,000 units of Becton Dickinson & Co stock on 15 August 2022 worth over $2,518,650. On average, Thomas trades about 4,022 units every 70 days since 2014. As of 15 August 2022 he still owns at least 43,878 units of Becton Dickinson & Co stock.
You can see the complete history of Mr. Polen stock trades at the bottom of the page.
Thomas E. Polen serves as President, Chief Executive Officer, Chief Operating Officer, Director of the Company. He was Executive Vice President and President - Medical Segment from October 2014 to April 2017; and Group President from October 2013 to October 2014.
As the President, Chief Executive Officer, Chief Operating Officer és Director of Becton Dickinson & Co, the total compensation of Thomas Polen at Becton Dickinson & Co is $6,029,970. There are 2 executives at Becton Dickinson & Co getting paid more, with Vincent Forlenza having the highest compensation of $16,014,600.
Thomas Polen is 46, he's been the President, Chief Executive Officer, Chief Operating Officer és Director of Becton Dickinson & Co since 2020. There are 30 older and 4 younger executives at Becton Dickinson & Co. The oldest executive at Becton Dickinson & Co. is Marshall Larsen, 71, who is the Lead Independent Director.
Thomas's mailing address filed with the SEC is C/O BECTON, DICKINSON AND COMPANY, , FRANKLIN LAKES, NJ, 07417.
Over the last 22 years, insiders at Becton Dickinson & Co have traded over $106,782,599 worth of Becton Dickinson & Co stock and bought 23,860 units worth $1,771,828 . The most active insiders traders include Edward J Ludwig, William M Brown és Vincent A Forlenza. On average, Becton Dickinson & Co executives and independent directors trade stock every 20 days with the average trade being worth of $4,349,205. The most recent stock trade was executed by Roland Goette on 14 August 2024, trading 5,295 units of BDX stock currently worth $701,799.
Becton, Dickinson and Company is a global medical technology company. The Company is engaged in the development, manufacture and sale of a range of medical supplies, devices, laboratory equipment and diagnostic products used by healthcare institutions, physicians, life science researchers, and others.
Becton Dickinson & Co executives and other stock owners filed with the SEC include: